🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II Pediatric MATCH screening and multi-sub-trial studies how wel...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-07-31
Trial ID
NCT03155620
Treatments Being Tested
This is a Phase II, single-Arm, prospective study of neoadjuvant Ensartinib...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2022-08-17
Trial ID
NCT05380024
Treatments Being Tested
In lung cancer, ensartinib is effective in improving the prognosis of ALK p...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02-28
Trial ID
NCT06762327
Treatments Being Tested
This phase Ib trial finds the best dose and side effects of ensartinib and ...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-03-18
Trial ID
NCT04837716
Treatments Being Tested
This umbrella trial directed by next generation sequencing (NGS) includes p...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2024-11-01
Trial ID
NCT06563999
The purpose of this study is to estimate the effect of rifampicin or itraco...
Status
Unknown
Location
The Second Affiliated hospital of Zhejiang University School of Medicine
Start Date
2024-07
Trial ID
NCT06492525
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of a 2-year adju...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-03-15
Trial ID
NCT06772610
Treatments Being Tested
This study explores how adjuvant therapy affects survival in completely res...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-05
Trial ID
NCT06955325
Treatments Being Tested
This National Cancer Institute (NCI)-NRG ALK Protocol phase II trial studie...
Status
Terminated
Location
CTCA at Western Regional Medical Center
Start Date
2019-07-25
Trial ID
NCT03737994
Treatments Being Tested
This phase II Pediatric MATCH treatment trial studies how well ensartinib w...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2018-04-17
Trial ID
NCT03213652